Stock AnalizCorteva, Inc. CTVA
Farming/Seeds/Milling · IPO 2019 · data as of November 13, 2026
Corteva, Inc. (CTVA) is a consumer staples company listed in the US with a market value of about $6.3B. In the twelve months to September 30, 2026 it had revenue of $17.7B and net income of $759M, a net margin of 4.3%.
Its overall Stock Analiz score is 3.0 out of 5 (average). The strongest part is value (4/5); the weakest is track record (2/5).
Key numbers: a P/E of 7.3, 5-year revenue growth of 4% a year, a 5-year average ROIC of 4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 112% above the current price.
Score: 3.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Checks not passed
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- ROE above 15%
- Positive free cash flow
- Debt below 3 years of free cash flow
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.7B | $17.4B | $16.9B | $17.2B | $17.5B | $15.7B | $14.2B | $13.8B | $14.3B |
| Net income | $759M | $1.1B | $907M | $735M | $1.1B | $1.8B | $681M | -$959M | -$5.1B |
| Free cash flow | -$149M | $2.8B | $1.5B | $1.2B | $267M | $2.2B | $1.6B | -$93M | -$1.0B |
| EPS (diluted) | $1.14 | $1.60 | $1.30 | $1.03 | $1.58 | $2.37 | $0.91 | $-1.28 | $-6.76 |
| Net margin | 4.3% | 6.3% | 5.4% | 4.3% | 6.6% | 11.2% | 4.8% | -6.9% | -35.4% |
| ROIC | — | 4.5% | 3.2% | 3.4% | 4.5% | 6.8% | 2.0% | -1.1% | -8.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 15 analysts is $14.63, 55% above the current price; targets range from $10.00 to $20.00; the consensus rating is “Buy”; expected EPS is $0.93 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Corteva’s P/E ratio?
About 7.3, based on the last twelve months of diluted earnings per share (forward P/E about 10.5).
Is Corteva stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 112% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Corteva pay a dividend?
Yes. The dividend yield is about 7.64%, and it has paid dividends for 5 years in our data.
Is Corteva a good stock to buy?
We do not give buy or sell advice. Corteva scores 3.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.